Pembrolizumab-Induced Anti-GBM Glomerulonephritis: A Case Report

Pembrolizumab-Induced Anti-GBM Glomerulonephritis: A Case Report

Immune checkpoint inhibitors are known to have a wide range of autoimmune toxicities, such as acute interstitial nephritis. Immunotherapy induced glomerulonephritis has been described, but anti-glomerular basement membrane disease (anti-GBM) is rarely reported. We present a case report of a 60-year-...

Full description

Bibliographic Details
Main Authors: Nidal El Yamani, Gabrielle Cote, Julie Riopel, Nicolas Marcoux, Fabrice Mac-Way, David Philibert, Mohsen Agharazii
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:Kidney Medicine
Subjects:
Immunotherapy
checkpoint inhibitors
glomerulonephritis
anti- GBM
cancer
kidney failure
Online Access:http://www.sciencedirect.com/science/article/pii/S2590059523000985

Internet

http://www.sciencedirect.com/science/article/pii/S2590059523000985

Similar Items